No standard treatment is available for advanced pancreatic cancer

Author： Lionetto R.   Pugliese V.   Bruzzi P.   Rosso R.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.6, 1995-06, pp. : 882-887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Pancreatic Cancer: Current and Future Treatment Options

By Papadopoulos K.P.   Sherman W.H.  

American Journal of Cancer, Vol. 1, Iss. 5, 2002-01 ,pp. : 323-340

Adis International

Access to resources Recommend Favorite

Regional chemotherapy in the treatment of advanced pancreatic cancer- is it relevant?

By Lorenz M.   Heinrich S.   Staib-Sebler E.   Kohne C.-H.   Wils J.   Nordlinger B.   Encke A.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 957-965

Elsevier

Access to resources Recommend Favorite

Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancer

By Welch Stephen A   Moore Malcolm J  

Future Oncology, Vol. 3, Iss. 3, 2007-06 ,pp. : 247-254

Future Medicine

Access to resources Recommend Favorite

Recent Advances in Combined Modality Treatment for Locally Advanced Pancreatic Cancer

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 3, 2005-11 ,pp. : 227-237

Bentham Science Publishers

Access to resources Recommend Favorite

Erlotinib: In Advanced Pancreatic Cancer

By Simpson Dene   Scott Lesley J.   Noble Stuart  

American Journal of Cancer, Vol. 5, Iss. 1, 2006-01 ,pp. : 35-40

Adis International

Access to resources Recommend Favorite